Not yet recruitingNot applicableNCT07208526

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Zhongshan Hospital
Principal Investigator
Jia Fan, MD&PhD
Shanghai Zhongshan Hospital
Intervention
GOLP regimen(drug)
Enrollment
270 enrolled
Eligibility
18-75 years · All sexes
Timeline
2025 – 2028

Study locations (1)

Collaborators

Shanghai Geriatric Medical Center · Shanghai Jiao Tong University Affiliated Sixth People's Hospital · Shanghai 10th People's Hospital · Oriental Hepatobiliary Surgery Hospital Affiliated to Naval Military Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07208526 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials